vs

Side-by-side financial comparison of Apyx Medical Corp (APYX) and UNITY BANCORP INC (UNTY). Click either name above to swap in a different company.

UNITY BANCORP INC is the larger business by last-quarter revenue ($35.3M vs $19.2M, roughly 1.8× Apyx Medical Corp). UNITY BANCORP INC runs the higher net margin — 43.9% vs -6.8%, a 50.6% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs 24.2%). UNITY BANCORP INC produced more free cash flow last quarter ($44.3M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 17.5%).

Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.

Unity Bancorp Inc is a New Jersey-headquartered financial holding company operating Unity Bank. It offers a full range of commercial and retail banking services including business loans, deposit products, mortgage services, and personal banking solutions, primarily serving small and medium-sized enterprises and individual consumers across local communities in New Jersey and eastern Pennsylvania.

APYX vs UNTY — Head-to-Head

Bigger by revenue
UNTY
UNTY
1.8× larger
UNTY
$35.3M
$19.2M
APYX
Growing faster (revenue YoY)
APYX
APYX
+10.6% gap
APYX
34.7%
24.2%
UNTY
Higher net margin
UNTY
UNTY
50.6% more per $
UNTY
43.9%
-6.8%
APYX
More free cash flow
UNTY
UNTY
$47.1M more FCF
UNTY
$44.3M
$-2.8M
APYX
Faster 2-yr revenue CAGR
APYX
APYX
Annualised
APYX
36.8%
17.5%
UNTY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
APYX
APYX
UNTY
UNTY
Revenue
$19.2M
$35.3M
Net Profit
$-1.3M
$15.5M
Gross Margin
62.6%
Operating Margin
0.1%
55.8%
Net Margin
-6.8%
43.9%
Revenue YoY
34.7%
24.2%
Net Profit YoY
71.9%
34.5%
EPS (diluted)
$1.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APYX
APYX
UNTY
UNTY
Q4 25
$19.2M
$35.3M
Q3 25
$12.9M
$32.8M
Q2 25
$11.4M
$34.4M
Q1 25
$9.4M
$29.4M
Q4 24
$14.2M
$28.4M
Q3 24
$11.5M
$27.7M
Q2 24
$12.1M
$25.5M
Q1 24
$10.2M
$25.6M
Net Profit
APYX
APYX
UNTY
UNTY
Q4 25
$-1.3M
$15.5M
Q3 25
$-2.0M
$14.4M
Q2 25
$-3.8M
$16.5M
Q1 25
$-4.2M
$11.6M
Q4 24
$-4.6M
$11.5M
Q3 24
$-4.7M
$10.9M
Q2 24
$-6.6M
$9.5M
Q1 24
$-7.6M
$9.6M
Gross Margin
APYX
APYX
UNTY
UNTY
Q4 25
62.6%
Q3 25
64.4%
Q2 25
62.3%
Q1 25
60.1%
Q4 24
63.0%
Q3 24
60.5%
Q2 24
61.7%
Q1 24
58.1%
Operating Margin
APYX
APYX
UNTY
UNTY
Q4 25
0.1%
55.8%
Q3 25
-6.5%
57.5%
Q2 25
-22.6%
62.6%
Q1 25
-32.4%
52.6%
Q4 24
-21.4%
51.0%
Q3 24
-31.6%
52.7%
Q2 24
-45.7%
49.3%
Q1 24
-64.6%
50.0%
Net Margin
APYX
APYX
UNTY
UNTY
Q4 25
-6.8%
43.9%
Q3 25
-15.4%
43.8%
Q2 25
-33.2%
48.0%
Q1 25
-44.0%
39.5%
Q4 24
-32.5%
40.5%
Q3 24
-40.9%
39.4%
Q2 24
-54.0%
37.1%
Q1 24
-74.0%
37.5%
EPS (diluted)
APYX
APYX
UNTY
UNTY
Q4 25
$1.52
Q3 25
$1.41
Q2 25
$1.61
Q1 25
$1.13
Q4 24
$1.13
Q3 24
$1.07
Q2 24
$-0.19
$0.92
Q1 24
$-0.22
$0.94

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APYX
APYX
UNTY
UNTY
Cash + ST InvestmentsLiquidity on hand
$31.7M
Total DebtLower is stronger
$37.5M
Stockholders' EquityBook value
$14.5M
$345.6M
Total Assets
$66.8M
$3.0B
Debt / EquityLower = less leverage
2.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APYX
APYX
UNTY
UNTY
Q4 25
$31.7M
Q3 25
$25.1M
Q2 25
$29.3M
Q1 25
$31.0M
Q4 24
$31.7M
Q3 24
$28.0M
Q2 24
$32.7M
Q1 24
$37.3M
Total Debt
APYX
APYX
UNTY
UNTY
Q4 25
$37.5M
Q3 25
$37.5M
Q2 25
$37.5M
Q1 25
$37.5M
Q4 24
$37.5M
$230.8M
Q3 24
$37.5M
Q2 24
Q1 24
Stockholders' Equity
APYX
APYX
UNTY
UNTY
Q4 25
$14.5M
$345.6M
Q3 25
$5.8M
$334.0M
Q2 25
$7.3M
$319.8M
Q1 25
$10.5M
$306.1M
Q4 24
$14.2M
$295.6M
Q3 24
$11.0M
$284.3M
Q2 24
$14.7M
$273.4M
Q1 24
$20.3M
$266.8M
Total Assets
APYX
APYX
UNTY
UNTY
Q4 25
$66.8M
$3.0B
Q3 25
$57.4M
$2.9B
Q2 25
$58.2M
$2.9B
Q1 25
$60.2M
$2.8B
Q4 24
$64.8M
$2.7B
Q3 24
$60.7M
$2.6B
Q2 24
$65.4M
$2.6B
Q1 24
$70.7M
$2.6B
Debt / Equity
APYX
APYX
UNTY
UNTY
Q4 25
2.58×
Q3 25
6.41×
Q2 25
5.17×
Q1 25
3.57×
Q4 24
2.64×
0.78×
Q3 24
3.40×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APYX
APYX
UNTY
UNTY
Operating Cash FlowLast quarter
$-2.5M
$44.9M
Free Cash FlowOCF − Capex
$-2.8M
$44.3M
FCF MarginFCF / Revenue
-14.6%
125.7%
Capex IntensityCapex / Revenue
1.4%
1.6%
Cash ConversionOCF / Net Profit
2.90×
TTM Free Cash FlowTrailing 4 quarters
$-9.1M
$81.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APYX
APYX
UNTY
UNTY
Q4 25
$-2.5M
$44.9M
Q3 25
$-3.5M
$45.5M
Q2 25
$-1.2M
$-25.3M
Q1 25
$-702.0K
$17.9M
Q4 24
$-2.9M
$48.0M
Q3 24
$-4.4M
$17.7M
Q2 24
$-4.3M
$-8.4M
Q1 24
$-6.3M
$15.8M
Free Cash Flow
APYX
APYX
UNTY
UNTY
Q4 25
$-2.8M
$44.3M
Q3 25
$-4.1M
$45.3M
Q2 25
$-1.5M
$-25.5M
Q1 25
$-757.0K
$17.6M
Q4 24
$-3.2M
$47.3M
Q3 24
$-4.6M
$17.5M
Q2 24
$-4.6M
$-8.6M
Q1 24
$-6.4M
$15.7M
FCF Margin
APYX
APYX
UNTY
UNTY
Q4 25
-14.6%
125.7%
Q3 25
-31.5%
138.1%
Q2 25
-13.2%
-74.2%
Q1 25
-8.0%
59.9%
Q4 24
-22.4%
166.5%
Q3 24
-40.0%
63.3%
Q2 24
-38.0%
-33.7%
Q1 24
-62.2%
61.4%
Capex Intensity
APYX
APYX
UNTY
UNTY
Q4 25
1.4%
1.6%
Q3 25
4.0%
0.7%
Q2 25
2.3%
0.5%
Q1 25
0.6%
1.0%
Q4 24
1.7%
2.4%
Q3 24
1.3%
0.5%
Q2 24
2.4%
0.5%
Q1 24
0.3%
0.3%
Cash Conversion
APYX
APYX
UNTY
UNTY
Q4 25
2.90×
Q3 25
3.16×
Q2 25
-1.54×
Q1 25
1.54×
Q4 24
4.17×
Q3 24
1.62×
Q2 24
-0.89×
Q1 24
1.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons